96454 ⎘
Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane; Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified Esters
LYMPH DIRECTING PRODRUGS
#2LYMPH DIRECTING PRODRUGS
#3PRODRUGS FOR DELIVERY OF TESTOSTERONE TO THE CENTRAL NERVOUS SYSTEM
#4LYMPH DIRECTING PRODRUGS
#5LYMPH DIRECTING PRODRUGS
#6LYMPH DIRECTING PRODRUGS
#7LYMPH DIRECTING PRODRUGS
#8LYMPH DIRECTING PRODRUGS
#9LYMPH DIRECTING PRODRUGS
#10LYMPH DIRECTING PRODRUGS
#11(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
#12(17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods of their preparation and use
#13LYMPH DIRECTING PRODRUGS
#14Lymph directing prodrugs
#15(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
#16Lymph directing prodrugs
#17(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
#18PROGESTERONE RECEPTOR ANTAGONISTS AND USES THEREOF
#19METHODS AND COMPOUNDS FOR PREPARING 3ALPHA-OXYGEN SUBSTITUTED STEROIDS
#20Steroid compounds and treatment methods
#21PROCESS FOR OBTAINING 6-ALKYLIDENANDROST-1, 4-DIENE-3-ONE
#22Steroid compounds and formulations
#23Compounds and compositions
#24Cancer treatment methods
#25Allylic oxidations catalyzed by dirhodium catalysts under aqueous conditions
#26Breast and prostate cancer treatment method
#27Formulations
#28Pharmaceutical compositions
#29Formulations and Treatment Methods
#30Pharmaceutical treatments and compositions
#31Androgenic 7-substituted 11-halogen steroids